A Study to Reduce Disparities in High-Risk Black Men (BM) With Advanced Prostate Cancer Using Patient-Centered Home Care


About this study

The purpose of this study is to evaluate a highly innovative project evaluating the feasibility of patient-centered home care (PCHC) as a new model of cancer care to reduce disparities and improve health related qualtiy of life (HRQoL) and patient reported-outcomes (PROs) in Black patients with advanced prostate cancer (CaP).


Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Are 18 years of age or older.
  • Have histologic evidence of prostate adenocarcinoma.
  • Are requiring active standard hormone-based therapies (degarelix or leuprolide), antibone resorptive agents (zoledronic acid or denosumab), oral anticancer treatments (abiraterone or second-generation androgen receptor blockers) or intravenous chemotherapy (docetaxel).
  • Are receiving part of supportive care/symptom management and/or anti-cancer therapy in the home as part of advanced care at home program (ACH).
  • Have an understanding of the protocol and its requirements.
  • are able and willing to sign an informed consent.

Exclusion Criteria:

  • Does not identify as a Black man.
  • Has not been diagnosed with advanced/metastatic CaP (Advanced Prostate Cancer) from the Mayo Clinic genitourinary cancer clinical practice.
  • Are not requiring active standard anti-cancer therapy.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Roxana Dronca, M.D.

Contact us for the latest status

Contact information:

Nicole Fitzgibbon


More information


Publications are currently not available

Mayo Clinic Footer